Chemoinformaics analysis of 5,6,9-TRIMETHYLTETRACYCLO[7.2.1.01,6.08,10]DODECANE
Molecular Weight | 204.357 | nRot | 0 |
Heavy Atom Molecular Weight | 180.165 | nRig | 2 |
Exact Molecular Weight | 204.188 | nRing | 5 |
Solubility: LogS | -3.293 | nHRing | 0 |
Solubility: LogP | 3.851 | No. of Aliphatic Rings | 5 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 4 | No. Saturated Carbocycles | 5 |
No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 5 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 0 | APOL | 41.053 |
nHD | 0 | BPOL | 24.077 |
QED | 0.448 |
Synth | 4.07 |
Natural Product Likeliness | 2.158 |
NR-PPAR-gamma | 0.766 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0 |
Pgp-sub | 0.01 |
HIA | 0.82 |
CACO-2 | -4.184 |
MDCK | 0.000031 |
BBB | 0.412 |
PPB | 0.988742 |
VDSS | 1.684 |
FU | 0.0162969 |
CYP1A2-inh | 0.14 |
CYP1A2-sub | 0.411 |
CYP2c19-inh | 0.894 |
CYP2c19-sub | 0.49 |
CYP2c9-inh | 0.782 |
CYP2c9-sub | 0.983 |
CYP2d6-inh | 0.005 |
CYP2d6-sub | 0.288 |
CYP3a4-inh | 0.447 |
CYP3a4-sub | 0.068 |
CL | 10.686 |
T12 | 0.246 |
hERG | 0.007 |
Ames | 0.54 |
ROA | 0.706 |
SkinSen | 0.874 |
Carcinogencity | 0.514 |
EI | 0.415 |
Respiratory | 0.961 |
NR-Aromatase | 0.902 |
Antiviral | Yes |
Prediction | 0.907264 |